Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment
Open Access
- 16 July 2018
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-13
Abstract
Enhancement of hematopoietic stem cell (HSC) homing and engraftment is clinically critical, especially for cord blood (CB) hematopoietic cell transplantation. Here we report that specific HDAC5 inhibition highly upregulates CXCR4 surface expression in human CB HSCs and progenitor cells (HPCs). This results in enhanced SDF-1/CXCR4-mediated chemotaxis and increased homing to the bone marrow environment, with elevated SCID-repopulating cell (SRC) frequency and enhanced long-term and secondary engraftment in NSG mice. HDAC5 inhibition increases acetylated p65 levels in the nucleus, which is important for CXCR4 transcription. Inhibition of nuclear factor-κB (NF-κB) signaling suppresses HDAC5-mediated CXCR4 upregulation, enhanced HSC homing, and engraftment. Furthermore, activation of the NF-κB signaling pathway via TNFα also results in significantly increased CXCR4 surface expression, enhanced HSC homing, and engraftment. These results demonstrate a previously unknown negative epigenetic regulation of HSC homing and engraftment by HDAC5, and allow for a new and simple translational strategy to enhance HSC transplantation.Keywords
Funding Information
- National Institutes of Health (R01 HL112669, R01 HL056416, U54 DK106846, R35 HL139599)
This publication has 54 references indexed in Scilit:
- The Intricate Role of CXCR4 in Cancer2014
- RhoGTPases control specific cytoskeleton‐dependent functions of hematopoietic stem cellsImmunological Reviews, 2013
- Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer CellsJournal of Medicinal Chemistry, 2012
- Hematopoiesis: A Human PerspectiveCell Stem Cell, 2012
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem CellsScience, 2010
- The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in VitroJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- HATs and HDACs: from structure, function and regulation to novel strategies for therapy and preventionOncogene, 2007
- cAMP-induced PKCζ activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitorsBlood, 2006
- Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4Science, 1999